Eiger BioPharmaceuticals Inc (EIGRQ)
OTCMKTS: EIGRQ · Delayed Price · USD
10.20
+0.20 (2.00%)
Jun 21, 2024, 3:53 PM EDT - Market closed

Eiger BioPharmaceuticals Revenue

In the year 2023, Eiger BioPharmaceuticals had annual revenue of $15.77M with 16.98% growth. Revenue in the quarter ending December 31, 2023 was $3.80M with 41.06% year-over-year growth.

Revenue (ttm)
$15.77M
Revenue Growth
+16.98%
P/S Ratio
0.96
Revenue / Employee
$630,920
Employees
25
Market Cap
15.10M

Revenue Chart

* The company reports in USD currency but revenue data is shown in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202315.77M2.29M16.98%
Dec 31, 202213.48M1.34M11.05%
Dec 31, 202112.14M--
Dec 31, 20200--
Dec 31, 20190--
Dec 31, 20180--
Dec 31, 20170--
Dec 31, 20160--
Dec 31, 20150--
Dec 31, 20140--
Dec 31, 20130--
Dec 31, 20120--
Jun 30, 20110--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 379.49B
Johnson & Johnson 81.80B
Merck & Co. 61.40B
AbbVie 54.40B
Novartis AG 49.92B
AstraZeneca 47.61B
Thermo Fisher 42.49B
Abbott Laboratories 40.33B
Revenue Rankings